Observational study of ovarian cancer from 2021 onward
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at the real-world experiences of patients with ovarian cancer, whether newly diagnosed or with persistent or recurrent disease. It aims to learn more about the disease and its treatment over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have ovarian cancer that is newly diagnosed (stages IA to IVB) or that came back or didn't go away (persistent or recurrent) starting from January 2021.
- Your tumor can be any type (any histology).
- You do not have a borderline tumor.
- You are not pregnant.
- You have not had another cancer in the last 5 years (except certain skin cancers or thyroid cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This study aims to improve care for ovarian cancer by including people at different stages: those being checked for it, those with known risk factors, and those who are generally healthy. It could help researchers better understand and support patients and their families.
This research study follows patients with epithelial ovarian cancer that has returned or worsened quickly after treatment (within 6 months). The goal is to understand survival patterns and outcomes in these difficult-to-treat cases to potentially improve future care.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
This study looks at metastatic ovarian cancer by analyzing many types of patient data (from “multi-omics,” which means different kinds of lab and biological information). It may help doctors better understand the disease and improve future care.
This registry collects information from people with advanced ovarian or endometrial cancer to better understand care and outcomes. It may help researchers and doctors learn which treatments work best for different patients.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.